Executive Compensation Report By Executive

Y. Paul Goldberg Senior Vice President, Clinical Development XENON PHARMACEUTICALS INC
Y. Tristan Kuo CFO AERKOMM INC.
Y. Vicky Chou Senior Vice President of Global Management and General Counsel OMNIVISION TECHNOLOGIES INC
Ya-Ju Chang Former Principal Financial Officer, Secretary and Treasurer LAZURITON NANO BIOTECHNOLOGY (U.S.A.) INC.
Yadong Liu Chief Executive Officer CEFC GLOBAL STRATEGIC HOLDINGS, INC.
Yahia Gawad Dr. Chief Executive Officer CARDIOGENICS HOLDINGS INC
Yair Fudim CEO PEREGRINE INDUSTRIES INC
Yakov Faitelson Chief Executive Officer and President VARONIS SYSTEMS INC
Yakov Kogan Chief Executive Officer CLEVELAND BIOLABS INC
Yaky Yanay Co-CEO and President PLURISTEM THERAPEUTICS INC
Yam Chi Wah Chief Financial Officer TRANSAKT LTD
Yamo Deniz M.D. Chief Medical Officer FLEXION THERAPEUTICS INC
Yan Li CEO JUBILANT FLAME INTERNATIONAL, LTD
Yan Zhang Former Director of Public Relations and Director INTERNATIONAL LEADERS CAP CO
Yana Kravtsova Senior Vice President, General Counsel and Secretary TERRAFORM GLOBAL INC
Yancey Spruill Chief Financial Officer, Chief Operating Officer and Treasurer SENDGRID INC
Yang Liu President, CEO, CFO, and director NOGALES RESOURCES CORP
Yang Liu CEO WAVE SYNC CORP.
Yang (Roy) Yu Chief Financial Officer PINGTAN MARINE ENTERPRISE
Yanika Silina CFO CELL MEDX CORP
Yaniv Arieli Chief Financial Officer CEVA INC
Yaohsu (Joseph) WANG Former CEO, CFO and Secretary THERON RESOURCE GROUP
Yap Cheng Wah COO and Director of the Company GUSHEN, INC
Yarlagadda S. Babu Ph.D. Senior Vice President of Drug Discovery BIOCRYST PHARMACEUTICALS INC
Yaron Werber MD, MBA Chief Business and Financial Officer and Treasurer OVID THRPUTCS INC
Yaroslav Startsev President, CEO KINETIC GROUP INC.
Yaru Huang CFO, Director FLURIDA GROUP INC
Yasef Murat Senior Manufacturing Fellow INNOPHOS HOLDINGS INC
Yash Puri Former Executive Vice President, Chief Financial Officer and Treasurer ECOARK HOLDINGS INC
Yasir B. Al-Wakeel Former Chief Financial Officer and Head of Corporate Development MERRIMACK PHARMACEUTICALS